DSG3 and pemphigus vulgaris: For example, CAAR-T cells engineered to recognize desmoglein-3 (Dsg3) have demonstrated efficacy in eliminating Dsg3-specific B cells, ameliorating symptoms in pemphigus vulgaris (PV) (54).